The knee is the joint that is most commonly affected by osteoarthritis. According to the World Health Organization (WHO), knee osteoarthritis currently affects about 365 million people worldwide.
A recent study conducted by a research team in Italy has demonstrated the safety and tolerance of injecting a specific type of stem cell into the brains of individuals suffering from progressive multiple sclerosis (MS). Notably, this treatment has shown a prolonged effect that seems to safeguard the brain against future harm.
Recently, significant advancements have been made in stem cell treatment for diabetes. This year, Vertex released clinical data on its continuing stem cell therapy for diabetes treatment. Two patients with type I diabetes, who underwent stem cell therapy for over a year, no longer require insulin injections, and have shown remarkable improvements in their diabetes-related symptoms and biochemical indicators. Today, we will discuss the effectiveness and obstacles of stem cell treatment for diabetes based on literature reports, aiming to enhance everyone’s understanding of this innovative approach.
Chronic obstructive pulmonary disease (COPD) is an umbrella term for a collection of progressive respiratory conditions, all of which cause breathing difficulties.
Mesenchymal stem cells (MSCs) are considered to be an effective tool for treating chronic diseases due to their multi-lineage differentiation potential, immune regulatory capabilities, and ability to secrete anti-inflammatory factors. Increasingly, scientists are applying MSCs in clinical research for the treatment of chronic diseases such as neurodegenerative diseases, autoimmune diseases, and cardiovascular diseases and have achieved positive clinical outcomes.
Three boys from New South Wales, Australia have been recruited to participate the world first trial for kids aged under four with Duchenne Muscular Dystrophy.
Muscular dystrophy is a group of diseases that cause progressive weakness and loss of muscle mass. In muscular dystrophy, abnormal genes (mutations) interfere with the production of proteins needed to form healthy muscle.
Muscular dystrophy (MD) refers to a group of genetic diseases that cause progressive weakness and degeneration of skeletal muscles. These disorders (of which there are more than 30) vary in age of onset, severity, and the pattern of the affected muscles.
Multiple sclerosis (MS) is a chronic neurological disease that affects the body’s central nervous system, about 2.8 million people around the world are struggling from this terrible disease.
Muscular dystrophies are a group of different genetic diseases characterized by progressive weakness due to degeneration of the muscles that control movement. Some forms are seen in childhood, but other types may begin later in life. The disorders differ in terms of the distribution of and extent of muscle weakness, rate of progression and pattern of inheritance.